Prussian Blue as an Antidote for Radioactive Poisoning

Introduction

Radioactive contamination can occur during nuclear accidents, radiological disasters, or the detonation of nuclear weapons. In such events, individuals may be exposed to radioactive isotopes that enter the body through inhalation, ingestion, or open wounds. Once inside the body, these radioactive materials emit ionizing radiation that can damage tissues, disrupt cellular functions, and increase the long-term risk of cancer.

Among the radionuclides released during nuclear incidents, Cesium-137 and Thallium isotopes are particularly dangerous because they distribute throughout body tissues and remain biologically active for long periods. Medical management of such contamination focuses on reducing the radioactive burden within the body.

One of the most effective pharmaceutical countermeasures for internal contamination with cesium and thallium is Prussian Blue, a compound capable of binding radioactive ions in the gastrointestinal tract and facilitating their removal from the body.

What is Prussian Blue?

Prussian Blue is a dark blue coordination compound chemically known as ferric hexacyanoferrate(II) with the chemical formula Fe₄[Fe(CN)₆]₃. Although it was originally discovered in the early 18th century as a pigment used in dyes and paints, its unique crystal structure later attracted scientific interest for medical applications.

In pharmaceutical medicine, insoluble Prussian Blue is used as an oral antidote for radioactive poisoning caused by cesium-137 and thallium. The compound has a porous lattice structure capable of trapping positively charged metal ions. Because of this property, it functions as an ion-exchange agent that binds radioactive isotopes in the digestive tract.

The compound was first synthesized accidentally in 1704 in Berlin by paint-maker Johann Jacob Diesbach. Later, during the 1960s and 1970s, its therapeutic value was recognized, leading to its inclusion in national radiological emergency protocols. It is now listed by the World Health Organization and approved by the U.S. Food and Drug Administration under the trade name Radiogardase®.

Other formulations developed for radiological emergency preparedness include Pru-Decorp capsules, which contain Prussian Blue as the active binding agent. These capsules are designed to help remove radioactive cesium and thallium from the body following nuclear emergencies.

Mechanism of Action in Cesium and Thallium Poisoning

The effectiveness of Prussian Blue as an antidote lies in its ability to bind radioactive ions and prevent their reabsorption in the body.

Binding of Radioactive Isotopes

The crystal lattice structure of Prussian Blue contains negatively charged cavities that attract and bind positively charged metal ions. When ingested, Prussian Blue remains largely confined to the gastrointestinal tract. Within the intestine, it binds strongly with radioactive ions such as Cesium-137 and Thallium.

Cesium behaves chemically similar to potassium and can spread throughout the body’s tissues. However, when Prussian Blue is present in the digestive system, cesium ions released into bile and intestinal fluids bind to the compound instead of being reabsorbed.

Elimination from the Body

Once bound to Prussian Blue, the radioactive ions are trapped within the lattice structure and cannot pass back into the bloodstream. The complex is then eliminated from the body through fecal excretion.

This process significantly reduces the biological half-life of cesium and thallium, lowering the amount of radiation absorbed by tissues and decreasing the long-term health risk associated with radioactive contamination.

Recent Developments by DRDO

India’s Defence Research and Development Organisation (DRDO) has conducted research on medical countermeasures to protect individuals from radiological hazards during nuclear emergencies.

DRDO scientists have investigated the application of Prussian Blue-based formulations for rapid decorporation of radioactive isotopes. These developments aim to enhance the binding efficiency and adsorption capacity of Prussian Blue for radionuclides such as cesium-137.

Among the formulations developed under such research initiatives, specialized capsule preparations designed for emergency use are as follows:

Pru-Decorp Capsules

Prussian Blue capsules known as Pru-Decorp are developed as antidotes for radioactive cesium contamination, particularly Cs-137 exposure during nuclear emergencies.

Pru-Decorp-TM

Pru-Decorp-TM is a 500 mg hard gelatin capsule containing dark blue Prussian Blue powder with pharmaceutically acceptable excipients. It is designed for rapid administration during radiological emergencies to bind radioactive cesium and thallium.

Pru-Decorp-MG

Pru-Decorp-MG is a 1000 mg capsule containing insoluble Prussian Blue combined with binding-efficiency enhancer agents. This formulation has been developed particularly for rescue responders and emergency personnel who may face high-risk exposure in nuclear disaster scenarios.

Such developments highlight the growing importance of Prussian Blue-based medical countermeasures in national radiological emergency preparedness programs.

Dosage and Administration

The dosage of Prussian Blue depends on the level of radioactive contamination and the patient’s age group.

Adult Dosage

The commonly recommended dose for adults is 3 grams orally three times per day. The capsules may be swallowed whole or opened and mixed with food or liquid for easier administration.

Pediatric Dosage

For children, the typical dose is 1 gram orally three times per day. Dosing adjustments may be made based on body weight and the severity of contamination.

Duration of Treatment

Treatment duration varies depending on the amount of radioactive isotope present in the body. Therapy may continue for several weeks or even months until radionuclide levels decrease to safe levels.

Monitoring may include measurement of radioactive material in urine or fecal samples to assess the effectiveness of treatment.

Side Effects and Safety Profile

Prussian Blue is generally considered a safe and well-tolerated antidote because it is minimally absorbed into the bloodstream and acts primarily within the gastrointestinal tract.

Common Side Effects

The most frequently reported side effects include:

• Constipation

• Mild gastrointestinal discomfort

• Blue discoloration of stool

Possible Electrolyte Imbalance

In some cases, prolonged treatment may cause low potassium levels (hypokalemia) due to binding interactions in the intestine.

Contraindications and Precautions

Prussian Blue should be used cautiously in individuals with:

• Severe intestinal obstruction

• Certain gastrointestinal disorders

Medical supervision is recommended during prolonged therapy to monitor electrolyte balance and treatment progress.

Conclusion

Prussian Blue plays a critical role in the medical management of radioactive contamination. Through its ion-binding mechanism, the compound prevents the reabsorption of radioactive ions in the gastrointestinal tract and facilitates their elimination from the body.

With increasing global attention to nuclear safety and radiological emergency preparedness, pharmaceutical formulations such as Radiogardase and Pru-Decorp capsules have become essential tools in radiation medicine. Continued research, including developments by organizations such as DRDO, aims to further improve the effectiveness of Prussian Blue-based therapies in protecting populations from radioactive exposure.

Macsen Laboratories is a GMP and ISO certified manufacturer & supplier of Prussian Blue.

FAQs

Q. Does Prussian blue help with radiation?

Prussian Blue is used to reduce the impact of internal radiation exposure caused by radioactive cesium (Cs) or thallium (Tl).

Q. How does Prussian Blue remove cesium-137 from the body?

Prussian Blue works as an insoluble ion-exchange agent in the gastrointestinal tract. It binds to radioactive cesium-137 that enters the intestines through bile secretion. Once bound, it forms a stable complex that prevents the cesium from being reabsorbed into the bloodstream, allowing it to be eliminated from the body through feces.

Q. What dose of Prussian Blue is required for adults and children?

The dose of Prussian Blue depends on the patient and the type of exposure. Generally, adults and teenagers are prescribed 3 grams (about 6 capsules) three times a day for cesium or thallium contamination. However, the exact dose may vary based on age and medical condition, so it is recommended to follow healthcare professional guidance or the product label instructions.

Q. Why does Prussian blue work as an antidote when ingesting a lethal dose of thallium?

Prussian Blue acts as an effective antidote because of its strong ion-exchange properties. When ingested, it binds to thallium ions present in the gastrointestinal tract and interrupts their reabsorption cycle. This process increases the elimination of thallium from the body, reducing toxicity and helping lower the risk associated with thallium poisoning.

References

• https://www.macsenlab.com/active-pharmaceutical-ingredients/prussian-blue-14038-43-8/
• https://www.cdc.gov/radiation-emergencies/infographic/prussian-blue.html
• https://remm.hhs.gov/prussianblue.htm
• https://www.dovepress.com/prussian-blue-as-an-antidote-for-radioactive-thallium-and-cesium-poiso-peer-reviewed-fulltext-article-ODRR
• https://pmc.ncbi.nlm.nih.gov/articles/PMC5308456/
• https://link.springer.com/rwe/10.1007/978-3-319-17900-1_167

Disclaimer-

The information provided in this article is intended for educational and informational purposes only and is based on publicly available scientific literature and regulatory references related to Prussian Blue and radiological medicine. This content is not intended to serve as medical advice, diagnosis, or treatment guidance. The use of Prussian Blue or any medical countermeasure for radioactive contamination should be carried out only under the supervision of qualified healthcare professionals and appropriate regulatory authorities.

Macsen Labs is a manufacturer and supplier of high-quality Prussian Blue.